Let's focus on what we can do!

By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

  • Home
  • >
  • Epilepsy
  • >
  • Angelini Pharma's Ontozry available for patients in Scotland with drug-resistant epilepsy – PharmaTimes

Angelini Pharma's Ontozry available for patients in Scotland with drug-resistant epilepsy – PharmaTimes

Thursday, 10 February, 2022

Angelini Pharma's Ontozry available for patients in Scotland with drug-resistant epilepsy – PharmaTimes


SMC accepts promising new therapy which offers a better quality of life to patients with epilepsy
Around 55,000 people in Scotland are currently living with epilepsy. Significant treatment needs remain for those suffering from the treatment-resistant disease.
New hope, however, has been offered to adults in Scotland with uncontrolled focal epilepsy, as the Scottish Medicines Consortium (SMC) has acceptedOntozry(cenobamate) for adults with drug-resistant epilepsy.
Read more at: https://www.pharmatimes.com/news/angelini_pharmas_ontozry_available_for_patients_in_scotland_with_drug-resistant_epilepsy_1387480

Categories :
  • Epilepsy
  • Latest Headlines
Socials :

Recent posts